← Home
Pivot · July 28, 2026 · 1h 9m
Paramount Merger Pause, Meta AI Optimism, and the Peptide Boom
Kara and Scott analyze Paramount's decision to pause its merger with Warner Bros. Discovery, debate whether the deal will ultimately close, and discuss the strategic implications for the media industry. They critique Meta's latest AI ad campaign and propose better messaging, then examine Trump's lackluster White House Correspondents' Dinner performance and the FDA's recent easing of peptide restrictions driving a pharmaceutical and wellness boom.
This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.
Curious
•
Regulatory easing around peptides exemplifies how government policy shifts can rapidly commercialize emerging health categories that have been scientifically viable but legally constrained.
Highlights
Editorial
•
•
Misc
✧Meta's AI marketing campaign generates immediate skepticism from Scott despite industry optimism
✧Paramount merger pause signals deeper structural challenges in legacy media consolidation
✧Trump's WHCD appearance continues pattern of comedy missteps in formal settings
✧Peptide restrictions easing represents regulatory shift with significant health/wellness market implications
Was this useful?